DE3861494D1 - Pharmazeutische zusammensetzung zur behandlung von tumoren. - Google Patents

Pharmazeutische zusammensetzung zur behandlung von tumoren.

Info

Publication number
DE3861494D1
DE3861494D1 DE8888109121T DE3861494T DE3861494D1 DE 3861494 D1 DE3861494 D1 DE 3861494D1 DE 8888109121 T DE8888109121 T DE 8888109121T DE 3861494 T DE3861494 T DE 3861494T DE 3861494 D1 DE3861494 D1 DE 3861494D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
tumor treatment
tumor
treatment
dipyridamole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888109121T
Other languages
English (en)
Inventor
Nobuo Prof Dr Suzuki
Yoshiaki Dr Takakubo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of DE3861494D1 publication Critical patent/DE3861494D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8888109121T 1987-06-16 1988-06-08 Pharmazeutische zusammensetzung zur behandlung von tumoren. Expired - Fee Related DE3861494D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87108708A EP0295317A1 (de) 1987-06-16 1987-06-16 Pharmazeutische Zusammensetzung zur Behandlung von Tumoren

Publications (1)

Publication Number Publication Date
DE3861494D1 true DE3861494D1 (de) 1991-02-14

Family

ID=8197069

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888109121T Expired - Fee Related DE3861494D1 (de) 1987-06-16 1988-06-08 Pharmazeutische zusammensetzung zur behandlung von tumoren.

Country Status (11)

Country Link
US (1) US4997645A (de)
EP (2) EP0295317A1 (de)
JP (1) JPS63316722A (de)
KR (1) KR890000108A (de)
AT (1) ATE59780T1 (de)
AU (1) AU622404B2 (de)
DE (1) DE3861494D1 (de)
DK (1) DK328088A (de)
HU (1) HU200942B (de)
PH (1) PH27069A (de)
ZA (1) ZA884262B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215744A (en) * 1987-06-16 1993-06-01 Boehringer Ingelheim Gmbh Methods for the treatment of tumors
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
SE513429C2 (sv) * 1992-06-03 2000-09-11 Syntello Inc Preparat för aktivering av naturliga mördarceller, vilket preparat innehåller interferon alfa och biogena aminer
US6003516A (en) * 1992-06-03 1999-12-21 Maxim Pharmaceuticals, Inc. Method for treatment of cancer and infectious disease
US5480640A (en) * 1995-05-02 1996-01-02 Schering Corporation Alpha interferon for treating prostate cancer
US6155266A (en) 1995-05-08 2000-12-05 Maxim Pharmaceuticals, Inc. Method for treatment of cancer and infectious disease
US20020099003A1 (en) 1997-10-28 2002-07-25 Wilson Leland F. Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
US7064130B2 (en) * 2001-04-20 2006-06-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3031450A (en) * 1959-04-30 1962-04-24 Thomae Gmbh Dr K Substituted pyrimido-[5, 4-d]-pyrimidines
BG36086A1 (en) * 1982-01-19 1984-09-14 Glbov Method for inducing interferon

Also Published As

Publication number Publication date
EP0295559A2 (de) 1988-12-21
HUT47033A (en) 1989-01-30
DK328088D0 (da) 1988-06-15
EP0295559B1 (de) 1991-01-09
EP0295559A3 (en) 1989-03-08
JPS63316722A (ja) 1988-12-26
JPH0529365B2 (de) 1993-04-30
AU622404B2 (en) 1992-04-09
PH27069A (en) 1993-02-01
AU1768188A (en) 1988-12-22
US4997645A (en) 1991-03-05
EP0295317A1 (de) 1988-12-21
HU200942B (en) 1990-09-28
ZA884262B (en) 1990-02-28
ATE59780T1 (de) 1991-01-15
DK328088A (da) 1988-12-17
KR890000108A (ko) 1989-03-11

Similar Documents

Publication Publication Date Title
DE3689363D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung der Metastasen von Krebstumoren.
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
DE3878627T2 (de) Zusammensetzung zur oberflaechenbehandlung von kautschuk.
IT1223890B (it) Trattamento superficiale di refrattari
DE3682229D1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
DE68912155T2 (de) Antivirales Kombinationspräparat.
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
DE3687692T2 (de) Geschlechtshormone zur behandlung von immun-mangel-krankheiten.
FR2580642B1 (fr) 5-pyrimidinecarboxamides et traitement de la leucemie et des tumeurs en les utilisant
DE69034076T2 (de) Verwendung von Human-Beta-Interferon zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von chronischer Myeloidleukämie
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE79255T1 (de) Wirkstoffe zur verhuetung von tumormetastasen.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
DE3879709D1 (de) Platin-arzneimittel.
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
NO173145C (no) Fremgangsmaate for behandling av voerter
DE69118847T2 (de) Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
ATE74004T1 (de) Mischung zur behandlung von hypercholesterolemie.
ATE76418T1 (de) Oberflaechenbehandlung von polyolefinformkoerpern.
ATE70971T1 (de) Foerderung der heilung von meniskusgewebe.
IT8767423A0 (it) Impiego di composti aventi attivita' mitogena in terapia citostatica
NO912528D0 (no) Behandling av sykdommer forbundet med jodmangel.
ATE65398T1 (de) Verwendung von oxirancarbonsaeuren zur behandlung der hyperlipaemie.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee